NCT00328601View on ClinicalTrials.gov

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)

PHASE3CompletedINTERVENTIONAL

Enrollment

170

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

June 30, 2005

Conditions

Diabetic Polyneuropathy

Interventions

DRUG

Thioctic Acid

Trial Locations (5)

58100

Wolfson Medical Center, Diabetes Unit, Holon

91120

Haddassah Medical Center Ein Kerem, Diabetes Unit, Jerusalem

119048

Chair of Nervous Diseases of IM Sechenov Moscow Medical Academy at City Clinical Hospital, Moscow

125315

Chair of Endocrinology and Diabetology of Russian Medical Academy of Postgraduate Education at Central Clinical Hospital of Ministry of Communication RF, Moscow

127486

Federal Centre of Medical Social Expertise and Rehabilitation of Invalids, Centre Diabetic Food, Moscow

All Listed Sponsors

lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00328601 - Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) | Biotech Hunter | Biotech Hunter